Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
June 27, 2006
The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors
A Gils
Journal of Thrombosis and Haemostasis : JTH
|
March 17, 2010
Hot spots in TAFIa
A Gils
Journal of Thrombosis and Haemostasis : JTH
|
February 21, 2008
Which carboxypeptidase determines the antifibrinolytic potential?
A Gils
Thrombosis and Haemostasis
|
August 26, 1998
Modulation of plasminogen activator inhibitor 1 by Triton X-100--identification of two consecutive conformational transitions
A Gils, P J Declerck
Alimentary Pharmacology & Therapeutics
|
May 6, 2017
Editorial: variability in adalimumab trough and peak serum concentrations
N Vande Casteele, A Gils
Thrombosis and Haemostasis
|
November 3, 1998
Structure-function relationships in serpins: current concepts and controversies
A Gils, P J Declerck
The Journal of Biological Chemistry
|
May 9, 1997
Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1
A Gils, P J Declerck
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Inhibition of plasminogen activator inhibitor-1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs
K Verbeke, A Gils, P J Declerck
Biochemistry
|
June 11, 1996
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop
A Gils, I Knockaert, P J Declerck
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI-1 inhibitor
K Verbeke, A Gils, P J Declerck
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|
June 27, 2006
The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors
A Gils
Journal of Thrombosis and Haemostasis : JTH
|
March 17, 2010
Hot spots in TAFIa
A Gils
Journal of Thrombosis and Haemostasis : JTH
|
February 21, 2008
Which carboxypeptidase determines the antifibrinolytic potential?
A Gils
Thrombosis and Haemostasis
|
August 26, 1998
Modulation of plasminogen activator inhibitor 1 by Triton X-100--identification of two consecutive conformational transitions
A Gils, P J Declerck
Alimentary Pharmacology & Therapeutics
|
May 6, 2017
Editorial: variability in adalimumab trough and peak serum concentrations
N Vande Casteele, A Gils
Thrombosis and Haemostasis
|
November 3, 1998
Structure-function relationships in serpins: current concepts and controversies
A Gils, P J Declerck
The Journal of Biological Chemistry
|
May 9, 1997
Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1
A Gils, P J Declerck
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Inhibition of plasminogen activator inhibitor-1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs
K Verbeke, A Gils, P J Declerck
Biochemistry
|
June 11, 1996
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop
A Gils, I Knockaert, P J Declerck
Journal of Thrombosis and Haemostasis : JTH
|
March 6, 2004
Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI-1 inhibitor
K Verbeke, A Gils, P J Declerck
Page
of 6